Sept 12 (Reuters) - Neovasc Inc NVCN.TO :
* Neovasc provides Tiara clinical update
* Neovasc Inc - all cause, 30-day mortality in 33 patients who have reached 30 days post implant with Tiara is 12.1% (4/33) in Tiara trial
Sept 12 (Reuters) - Neovasc Inc NVCN.TO :
* Neovasc provides Tiara clinical update
* Neovasc Inc - all cause, 30-day mortality in 33 patients who have reached 30 days post implant with Tiara is 12.1% (4/33) in Tiara trial